These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4870683)

  • 21. Interferon induction in mice by uniform salt forms of Shigella sonnei lipopolysaccharide and its components.
    Lugowski C; Błach-Olszewska Z; Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):513-6. PubMed ID: 373682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Soluble surface antigens of virulent Sh. sonnei].
    Kovalevskaia IL; Shcheglova ES; Iarovaia LM; Korneeva SA; Solov'eva OG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Dec; (12):48-54. PubMed ID: 414488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Production of sera against a thermolabile antigen of Shigella sonnei and their immunoelectrophoretic examinations].
    Kühn H; Kemmer G; Seltmann G
    Z Allg Mikrobiol; 1972; 12(2):127-34. PubMed ID: 4563421
    [No Abstract]   [Full Text] [Related]  

  • 25. Serological and chemical studies of Sh. sonnei, Pseudomonas shigelloides and C27 strains.
    Rauss K; Kontrohr T; Vertényi A; Szendrei L
    Acta Microbiol Acad Sci Hung; 1970; 17(2):157-66. PubMed ID: 4992458
    [No Abstract]   [Full Text] [Related]  

  • 26. [Some indices of the chemical composition of the protein fractions of Sonne's dysentery bacilli].
    Omel'ianets TG; Galkina A
    Mikrobiol Zh; 1969; 31(5):487-91. PubMed ID: 4923944
    [No Abstract]   [Full Text] [Related]  

  • 27. [Citrate method of extracting antigens from Shigella sonnei. I. Comparison with other methods].
    Kamzolkina NB; Iarovaia LM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Feb; (2):72-7. PubMed ID: 6166136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between the loss of plasmid DNA and the transition from virulent phase I to avirulent phase II in Shigella sonnei].
    Sansonetti P; David M; Toucas M
    C R Seances Acad Sci D; 1980 Mar; 290(13):879-82. PubMed ID: 6771038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical studies on Trichophyton mentagrophytes.
    Nozawa Y; Noguchi T; Ito Y; Sudo N; Watanabe S
    Sabouraudia; 1971 Jul; 9(2):129-38. PubMed ID: 5165165
    [No Abstract]   [Full Text] [Related]  

  • 30. Composition of the protective antigen from the slime layer of Pseudomonas aeruginosa.
    Cha SC; Bass JA; Shetlar MR
    Tex Rep Biol Med; 1971; 29(3):265-72. PubMed ID: 5004935
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduction in immunity to its own colicin associated with antigen segregation from phase I to phase II in a wild strain of Shigella sonnei.
    Omori G; Yoshimura A
    Biken J; 1967 Mar; 10(1):33-5. PubMed ID: 4861253
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunochemical studies of the phytohemagglutinin, concanavalin A.
    Person DA; Markowitz H
    J Immunol; 1969 Aug; 103(2):225-32. PubMed ID: 4979587
    [No Abstract]   [Full Text] [Related]  

  • 33. The sugars and amino acids "building blocks" in S and R strains of different Brucella Serobiotypes, their cell walls and endotoxins.
    Parnas J; Tuszkiewicz M; Pleszczynska E; Poplawski S; Mardarowicz C
    Z Naturforsch B; 1968 Mar; 23(3):348-50. PubMed ID: 4385721
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparative immunochemical study of Shigella sonnei haptene polysaccharides.
    Kontrohr T
    Ann Immunol Hung; 1972; 16(0):249-54. PubMed ID: 4137499
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free endotoxin of Shigella sonnei phase I.
    Slopek S; Romanowska E; Gieldanowski J; Mulczyk M; Godzińska H
    Bull Acad Pol Sci Biol; 1969; 17(2):81-3. PubMed ID: 4911443
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunochemical analysis of a uronic acid polymer of Staphylococcus epidermidis, strain 53.
    McDonald HC; Karakawa WW
    J Immunol; 1970 Aug; 105(2):389-95. PubMed ID: 4988466
    [No Abstract]   [Full Text] [Related]  

  • 38. Outer membrane proteins of Shigella sonnei. I. Characterization of phase I, phase II and R-form Shigella sonnei.
    Adamus G; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):547-52. PubMed ID: 7006562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigenic composition of different forms of Sh. sonnei].
    Vaneeva NP; Khomenko NA; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):49-53. PubMed ID: 60855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsonizing properties of horse sera. II. Factors stimulating phagocytosis of Shigella sonnei (phase II) bacilli.
    Grzybek-Hryncewicz K; Ladosz J; Kubis K; Slopek S
    Arch Immunol Ther Exp (Warsz); 1966; 14(1):19-24. PubMed ID: 5331460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.